Monthly
US$200
Billed every month
Sign in to subscribeApplication numbers, product numbers and original fields are retained. Marketing status is shown as listed in the source.
Currently marketed products: 15 · Counts FDA prescription and OTC marketing categories as listed; discontinued or unknown categories are excluded.
| Application / product number | Brand name (original) | Applicant (original) | Dosage form (original) | Route (original) | Strength (original) | Earliest approval | RLD / RS | Marketing status (original) | Official source |
|---|---|---|---|---|---|---|---|---|---|
| A090977-001 | LANTHANUM CARBONATE | BARR LABORATORIES INC A WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 500MG BASE | 2022/01/27 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A090977-002 | LANTHANUM CARBONATE | BARR LABORATORIES INC A WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 750MG BASE | 2022/01/27 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A090977-003 | LANTHANUM CARBONATE | BARR LABORATORIES INC A WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 1GM BASE | 2022/01/27 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A090978-001 | LANTHANUM CARBONATE | NATCO PHARMA LTD | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 500MG BASE | 2017/08/11 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A090978-002 | LANTHANUM CARBONATE | NATCO PHARMA LTD | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 750MG BASE | 2017/08/11 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A090978-003 | LANTHANUM CARBONATE | NATCO PHARMA LTD | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 1GM BASE | 2017/08/11 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A202329-001 | LANTHANUM CARBONATE | ALKEM LABORATORIES LTD | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 500MG BASE | 2025/03/13 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A202329-002 | LANTHANUM CARBONATE | ALKEM LABORATORIES LTD | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 750MG BASE | 2025/03/13 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A202329-003 | LANTHANUM CARBONATE | ALKEM LABORATORIES LTD | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 1GM BASE | 2025/03/13 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206868-001 | LANTHANUM CARBONATE | INVAGEN PHARMACEUTICALS INC | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 500MG BASE | 2022/01/24 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206868-002 | LANTHANUM CARBONATE | INVAGEN PHARMACEUTICALS INC | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 750MG BASE | 2022/01/24 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206868-003 | LANTHANUM CARBONATE | INVAGEN PHARMACEUTICALS INC | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 1GM BASE | 2022/01/24 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N021468-001 | FOSRENOL | TAKEDA PHARMACEUTICALS USA INC | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 250MG BASE | 2004/10/26 | N / N | DISCONTINUED | openFDA ↗ |
| N021468-002 | FOSRENOL | TAKEDA PHARMACEUTICALS USA INC | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 500MG BASE | 2004/10/26 | Y / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N021468-003 | FOSRENOL | TAKEDA PHARMACEUTICALS USA INC | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 750MG BASE | 2005/11/23 | Y / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N021468-004 | FOSRENOL | TAKEDA PHARMACEUTICALS USA INC | TABLET, CHEWABLE | ORAL | LANTHANUM CARBONATE: EQ 1GM BASE | 2005/11/23 | Y / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
*PED rows, substance/product flags, use codes and delisting-request flags are retained without determining legal effect.
This column includes only source rows explicitly flagged DS. A PED row without that flag is not assigned one by this site.
| Application / product number | Patent number | Listed expiration | Substance / product flags | Use code | Delisting request | Official source |
|---|---|---|---|---|---|---|
| Not listed | ||||||
Latest exclusivity expiration: —
| Application / product number | Exclusivity code | Listed expiration | Official source |
|---|---|---|---|
| Not listed | |||
The four-zero filter applies only to matched rows: catalog holders, NHSA approval numbers, applications under review, and companies filing generics this year. Unmatched rows have no Chinese counts. Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Zhejiang Zhong Tong Pharma Co., Ltd. romanized | 国药准字H20263491See source | 2026/03/03 | Official source ↗ |
| Hangzhou An Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253619See source | 2025/03/11 | Official source ↗ |
| Natco Pharma Limited | 国药准字HJ20240159See source | 2024/12/06 | Official source ↗ |
| Natco Pharma Limited | 国药准字HJ20240160See source | 2024/12/06 | Official source ↗ |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20244877See source | 2024/09/10 | Official source ↗ |
| Wen Zhou Hai He Pharma Co., Ltd. romanized | 国药准字H20244505See source | 2024/07/30 | Official source ↗ |
| Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20244466See source | 2024/07/16 | Official source ↗ |
| Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20243904See source | 2024/06/04 | Official source ↗ |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243738See source | 2024/05/21 | Official source ↗ |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243739See source | 2024/05/21 | Official source ↗ |
| Mylan Laboratories Limited | 国药准字HJ20230116See source | 2023/10/18 | Official source ↗ |
| Shenyang Fu Ning Pharma Co., Ltd. romanized | 国药准字H20233126See source | 2023/02/07 | Official source ↗ |
| Shenyang Fu Ning Pharma Co., Ltd. romanized | 国药准字H20233125See source | 2023/02/07 | Official source ↗ |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20223690See source | 2022/09/20 | Official source ↗ |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20203039See source | 2022/03/15 | Official source ↗ |
| Sichuan Zi Hao Shi Dai Pharma Co., Ltd. romanized | 国药准字H20213953See source | 2021/12/27 | Official source ↗ |
| Shire Pharmaceuticals Ireland Limited | H20171351;H20171352500mg | 2012/02/10 | Official source ↗ |
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Shenyang Hua Tai Drug Research Co., Ltd. romanized | 国药准字H20233126See source | — | Official source ↗ |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20223690See source | — | Official source ↗ |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20244877See source | — | Official source ↗ |
| Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20244466See source | — | Official source ↗ |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20244505See source | — | Official source ↗ |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20203039See source | — | Official source ↗ |
| HAMOL LIMITED | H20171351500mg | — | Official source ↗ |
| Qing Shen Hong Hao Pharmaceutical Co., Ltd. romanized | 国药准字H20213953See source | — | Official source ↗ |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243738See source | — | Official source ↗ |
| Hangzhou An Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253619See source | — | Official source ↗ |
| Natco Pharma Limited | 国药准字HJ20240159See source | — | Official source ↗ |
| Zhejiang Zhong Tong Pharma Co., Ltd. romanized | 国药准字H20263491See source | — | Official source ↗ |
| Shenyang Hua Tai Drug Research Co., Ltd. romanized | 国药准字H20233126See source | — | Official source ↗ |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20223690See source | — | Official source ↗ |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20244505See source | — | Official source ↗ |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20203039See source | — | Official source ↗ |
| Takeda Pharmaceuticals International AG Ireland Branch | 国药准字HJ20171351See source | — | Official source ↗ |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243738See source | — | Official source ↗ |
| Hangzhou An Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253619See source | — | Official source ↗ |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20223690See source | — | Official source ↗ |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20244505See source | — | Official source ↗ |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20203039See source | — | Official source ↗ |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243738See source | — | Official source ↗ |
| Hangzhou An Yuan Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253619See source | — | Official source ↗ |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243738See source | — | Official source ↗ |
| Shenyang Fu Ning Pharma Co., Ltd. romanized | 国药准字H20233125See source | — | Official source ↗ |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243739See source | — | Official source ↗ |
| Shenyang Fu Ning Pharma Co., Ltd. romanized | 国药准字H20233125See source | — | Official source ↗ |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243739See source | — | Official source ↗ |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20243739See source | — | Official source ↗ |
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | CYHS2600761 | 2026/04/01 | Official source ↗ |
| Chengdu Zong Lian Medical Health Technology Co., Ltd. romanized; Tai Ji Group Sichuan Tai Ji Pharmaceutical Co., Ltd. romanized | CYHS2600492 | 2026/02/14 | Official source ↗ |
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | CYHS2600761 | 2026/04/01 | Official source ↗ |
| Chengdu Zong Lian Medical Health Technology Co., Ltd. romanized; Tai Ji Group Sichuan Tai Ji Pharmaceutical Co., Ltd. romanized | CYHS2600492 | 2026/02/14 | Official source ↗ |
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Nei Menggu Jing Dong Pharma Co., Ltd. romanized | Y20250000378 | 2026/10/12 | Official source ↗ |
| Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | Y20240001423 | 2026/07/20 | Official source ↗ |
| Ka Wen Di Xu (Tai Zhou) Pharma Co., Ltd. romanized | Y20240000789 | 2025/12/08 | Official source ↗ |
| Zhejiang Qian Yuan Hai Li Sheng Pharmaceutical Co., Ltd. romanized | Y20240000582 | 2026/01/30 | Official source ↗ |
| Kang Chen Pharma (Nei Menggu) Co., Ltd. romanized | Y20240000103 | 2025/11/25 | Official source ↗ |
| Hebei Hua Chen Pharma Group Co., Ltd. romanized | Y20240000166 | 2025/08/14 | Official source ↗ |
| Fujian Nan Fang Pharmaceutical Co., Ltd. romanized | Y20230001019 | 2026/06/02 | Official source ↗ |
| Zhejiang Guo Bang Pharma Co., Ltd. romanized | Y20220001199 | 2026/07/09 | Official source ↗ |
| Suzhou Zheng Ji Pharma Co., Ltd. romanized | Y20220000535 | 2025/03/18 | Official source ↗ |
| Shandong Qidu Pharmaceutical Co., Ltd. | Y20220000985 | 2025/04/29 | Official source ↗ |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20220001024 | 2024/06/28 | Official source ↗ |
| Hunan Hua Na Da Pharmaceutical Factory Shou Xing Drug Co., Ltd. romanized | Y20220000933 | 2026/01/17 | Official source ↗ |
| Shenyang Fu Ning Pharma Co., Ltd. romanized | Y20210001310 | 2024/01/17 | Official source ↗ |
| Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | Y20220000402 | 2024/11/09 | Official source ↗ |
| Hebei An Jian Cheng Yi Pharmaceuticals Technology Co., Ltd. romanized | Y20220000312 | 2025/07/29 | Official source ↗ |
| Matrix Pharmacorp Private Limited | Y20220000002 | 2026/03/05 | Official source ↗ |
| Sichuan Zi Hao Shi Dai Pharma Co., Ltd. romanized | Y20200001552 | 2026/07/27 | Official source ↗ |
| Jiangsu Pu Run Biopharmaceuticals Co., Ltd. romanized | Y20200001500 | 2024/11/19 | Official source ↗ |
| Natco Pharma Limited | Y20200001143 | 2025/12/25 | Official source ↗ |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | Y20170000984 | 2024/03/23 | Official source ↗ |
Not loaded
Chinese counts use complete ingredient, dosage-form and route matches. Unmatched and partial rows show name-source matching only and make no finding about Chinese approvals or filings. Trials cover registration-number years 2025/2026 only.
Comparison generated: 2026/11/13 18:41 · openFDA Orange Book ↗
Subscriptions
US$200
Billed every month
Sign in to subscribeUS$540
Billed every three months
US$180 per month
Sign in to subscribeUS$1,920
Billed every year
US$160 per month
Sign in to subscribeSeparate one-time purchase
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy